Weight-Loss implant could replace weekly shots
Disease control
Not yet recruiting
This early-stage study tests a small implant placed under the skin that releases semaglutide (the drug in Wegovy) over 4 weeks. It involves 20 otherwise healthy overweight or obese adults. The goal is to see if the implant is safe and how it compares to weekly injections.
Phase: PHASE1 • Sponsor: Vivani Medical, Inc • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC